Assignee
CANCER PREVENTION PHARMACEUTICALS INC
US·5 granted patents·1 pending application·4 citations·filing 2016–2024
Top patents by PatentIndex Score
6 records- 0186US10945981B2Methods for treating familial adenomatous polyposisCANCER PREVENTION PHARMACEUTICALS INC·Filed 2020·Granted Mar 16, 2021·3 cites·20 claims
- 0283US11529326B2Eflornithine and sulindac, fixed dose combination formulationCANCER PREVENTION PHARMACEUTICALS INC·Filed 2021·Granted Dec 20, 2022·1 cites·20 claims
- 0382US12350246B2Eflornithine and sulindac, fixed dose combination formulationCANCER PREVENTION PHARMACEUTICALS INC·Filed 2024·Granted Jul 8, 2025·0 cites·13 claims
- 0477US11925613B2Eflornithine and sulindac, fixed dose combination formulationCANCER PREVENTION PHARMACEUTICALS INC·Filed 2022·Granted Mar 12, 2024·0 cites·19 claims
- 0562US10973790B2Eflornithine and sulindac, fixed dose combination formulationCANCER PREVENTION PHARMACEUTICALS INC·Filed 2016·Granted Apr 13, 2021·0 cites·23 claims
- 0659US2022040130A1Methods for treating familial adenomatous polyposisCANCER PREVENTION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CANCER PREVENTION PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →